Related Experiment Video
Updated: May 20, 2026
08:08
Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
Computational study of ADD1 gene polymorphism associated with hypertension
1Medical & Biological Computing Laboratory, Bioinformatics Division, School of Biosciences and Technology, VIT University, Vellore 632014, Tamil Nadu, India.
Cell Biochemistry and Biophysics
|July 20, 2012
Summary
Genetic variations in the alpha adducin 1 (ADD1) gene, specifically non-synonymous single-nucleotide polymorphisms (nsSNPs), may increase hypertension risk. One key nsSNP (rs4961) alters protein structure and function.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Research
Background:
- Hypertension is a complex disease influenced by genetic factors.
- The alpha adducin 1 (ADD1) gene plays a role in blood pressure regulation.
- Understanding genetic variations like non-synonymous single-nucleotide polymorphisms (nsSNPs) is crucial for identifying hypertension risk.
Purpose of the Study:
- To identify and analyze nsSNPs in the ADD1 gene.
- To investigate the population-specific variability of these nsSNPs.
- To assess the potential impact of nsSNPs on protein structure and function, and their association with hypertension risk.
Main Methods:
- Bioinformatic analysis of 1,113 single-nucleotide polymorphisms (SNPs) in the ADD1 gene.
- Identification of nsSNPs and prediction of their damaging effects using computational algorithms.
- Analysis of SNP variability and minor allele frequency across different populations.
- Assessment of amino acid changes and their predicted impact on protein structure (coiled, disordered regions).
Main Results:
- Nine nsSNPs were identified in the ADD1 gene.
- Seven of these nsSNPs were predicted to have a significant damaging effect.
- One nsSNP, rs4961, showed substantial variability in minor allele frequency across populations.
- The rs4961 variant results in a glycine to tryptophan substitution in a coiled, disordered protein region, predicted to alter protein structure and function.
Conclusions:
- The nsSNP rs4961 in the ADD1 gene, causing a glycine to tryptophan change in a disordered region, may affect protein structure and function.
- This alteration is a potential risk factor for hypertension.
- Further functional studies are warranted to confirm the role of ADD1 nsSNPs in hypertension pathogenesis.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...